Quotes 5-day view Delayed Nyse
02/22/2021
02/23/2021
02/24/2021
02/25/2021
02/26/2021
Date
116.21(c)
117.49(c)
115.74(c)
114.63(c)
115.59(c)
Last
2 180 379
1 464 446
993 684
1 434 481
1 513 691
Volume
-2.53% +1.10% -1.49% -0.96% +0.84% Change
Sales 2021
9 552 M - -
Net income 2021
1 339 M - -
Net Debt 2021
3 103 M - -
P/E ratio 2021
11,8x
Yield 2021
2,06%
Sales 2022
8 215 M - -
Net income 2022
903 M - -
Net Debt 2022
3 224 M - -
P/E ratio 2022
17,0x
Yield 2022
2,20%
Capitalization
15 426 M 15 426 M -
EV / Sales 2021
1,94x
EV / Sales 2022
2,27x
Nbr of Employees
44 500
Free-Float
60,6%
Quest Diagnostics is the world's leading provider of diagnostics testing and information service for patients and health professionals. Net sales break down by activity as follows:
- testing and diagnostic services (95.8%): routine clinical testing, gene-based testing and advanced diagnostic and anatomica pathology diagnostic services;
- other (4.3%).
Notations Surperformance© of Quest Diagnostics
Trading Rating : Investor Rating :
All news about QUEST DIAGNOSTICS
News in other languages on QUEST DIAGNOSTICS
Analyst Recommendations on QUEST DIAGNOSTICS
CVS to offer companies COVID-19 testing program as U.S. cases rise
Duration :
Auto.
2 months
3 months
6 months
9 months
1 year
2 years
5 years
10 years
Max.
Period :
Day
Week
Technical analysis trends QUEST DIAGNOSTICS
Short Term Mid-Term Long Term Trends Bearish Neutral Bullish
Income Statement Evolution
Please enable JavaScript in your browser's settings to use dynamic charts.
Mean consensus
OUTPERFORM
Number of Analysts
18
Average target price
139,76 $
Last Close Price
115,59 $
Spread / Highest target
36,7%
Spread / Average Target
20,9%
Spread / Lowest Target
8,14%
Please enable JavaScript in your browser's settings to use dynamic charts.
Canada
Deutschland
España
France
Italia
Schweiz (DE)
United Kingdom
Report
